NYSEARCA:PJPInvesco Dynamic Pharmaceuticals ETF Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Invesco Dynamic Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $64.22 +0.51 (+0.80 %) (As of 05/28/2020 04:00 PM ET) Add Share Today's Range$64.22Now: $64.22▼$65.0050-Day Range$55.99MA: $61.75▼$64.4052-Week Range$47.14Now: $64.22▼$66.75Volume42,012 shsAverage Volume38,608 shsMarket Capitalization$359.63 millionP/E RatioN/ADividend Yield0.90%BetaN/A ProfileAdvanced ChartDividendInstitutional OwnershipHeadlinesOptions ChainSocial Media PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund normally invests at least 90% of its total assets in common stocks that consists of the Index. The Fund's investment advisor is Invesco PowerShares Capital Management LLC.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Invesco Dynamic Pharmaceuticals ETF. Previous Next 2.2 Community Rank Outperform VotesInvesco Dynamic Pharmaceuticals ETF has received 45 “outperform” votes. (Add your “outperform” vote.)Underperform VotesInvesco Dynamic Pharmaceuticals ETF has received 57 “underperform” votes. (Add your “underperform” vote.)Community SentimentInvesco Dynamic Pharmaceuticals ETF has received 55.88% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Invesco Dynamic Pharmaceuticals ETF and other stocks. Vote “Outperform” if you believe PJP will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PJP will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 1.7 Dividend Strength Dividend LeadershipInvesco Dynamic Pharmaceuticals ETF is a leading dividend payer. It pays a dividend yield of 0.90%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthInvesco Dynamic Pharmaceuticals ETF does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Invesco Dynamic Pharmaceuticals ETF insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.77 out of 5 stars Basic Details Issuer Invesco Fund NameInvesco Dynamic Pharmaceuticals ETF Tax ClassificationRegulated Investment Company SymbolNYSEARCA:PJP Inception Date6/23/2005 Fund ManagerPeter Hubbard, Michael Jeanette, Tony Seisser, Jonathan Nixon Webwww.invescopowershares.com Phone+1-800-9830903 Fund Focus Asset ClassEquity BenchmarkDynamic Pharmaceuticals Intellidex Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Fund Statistics Assets Under Management$355.01 million Average Daily Volume$35,352.70 Discount/Premium-0.03% ETF Expenses Management Fee0.50% Other Expenses0.06% Total Expenses0.56% Fee Waiver0.00% Net Expenses0.56%Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorInvesco Capital Management LLC CustodianThe Bank of New York Mellon Corporation DistributorInvesco Distributors, Inc. Transfer AgentThe Bank of New York Mellon Corporation Trustee Lead Market MakerIMC Chicago AMEX:PJP Rates by TradingView Receive PJP News and Ratings via Email Sign-up to receive the latest news and ratings for PJP and its competitors with MarketBeat's FREE daily newsletter. Invesco Dynamic Pharmaceuticals ETF (NYSEARCA:PJP) Frequently Asked Questions How has Invesco Dynamic Pharmaceuticals ETF's stock been impacted by COVID-19 (Coronavirus)? Invesco Dynamic Pharmaceuticals ETF's stock was trading at $55.29 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, PJP stock has increased by 16.2% and is now trading at $64.22. View which stocks have been most impacted by Coronavirus. How often does Invesco Dynamic Pharmaceuticals ETF pay dividends? What is the dividend yield for Invesco Dynamic Pharmaceuticals ETF? Invesco Dynamic Pharmaceuticals ETF announced a quarterly dividend on Monday, December 23rd. Investors of record on Tuesday, December 24th will be paid a dividend of $0.1619 per share on Tuesday, December 31st. This represents a $0.65 dividend on an annualized basis and a dividend yield of 1.01%. The ex-dividend date is Monday, December 23rd. This is a boost from Invesco Dynamic Pharmaceuticals ETF's previous quarterly dividend of $0.06. View Invesco Dynamic Pharmaceuticals ETF's dividend history. Has Invesco Dynamic Pharmaceuticals ETF been receiving favorable news coverage? News articles about PJP stock have trended somewhat negative this week, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Invesco Dynamic Pharmaceuticals ETF earned a media sentiment score of -1.8 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news aboutInvesco Dynamic Pharmaceuticals ETF. What other stocks do shareholders of Invesco Dynamic Pharmaceuticals ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other Invesco Dynamic Pharmaceuticals ETF investors own include Verizon Communications (VZ), iShares Russell 2000 ETF (IWM), iShares 20+ Year Treasury Bond ETF (TLT), Akcea Therapeutics (AKCA), Morgan Stanley (MS), Applied Materials (AMAT), Alibaba Group (BABA), BOX (BOX), Berkshire Hathaway (BRK.B) and Walt Disney (DIS). Who are Invesco Dynamic Pharmaceuticals ETF's key executives? Invesco Dynamic Pharmaceuticals ETF's management team includes the following people: H. Bruce Bond, Chairman of the Board of Trustee, Chief Executive Officer (Age 49)Bruce T. Duncan, Chief Financial Officer, Treasurer (Age 60)Kevin R. Gustafson, Chief Compliance Officer (Age 43)Keith A Ovitt, Secretary (Age 50)Ronn R. Bagge, Trustee (Age 55)Marc M Kole, Trustee (Age 53)D. Mark McMillan, Trustee (Age 49)Philip M. Nussbaum Mba, Trustee (Age 52)Donald H. Wilson, Trustee (Age 55) What is Invesco Dynamic Pharmaceuticals ETF's stock symbol? Invesco Dynamic Pharmaceuticals ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "PJP." Who are Invesco Dynamic Pharmaceuticals ETF's major shareholders? Invesco Dynamic Pharmaceuticals ETF's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Envestnet Asset Management Inc. (3.00%), Advisor Group Holdings Inc. (1.03%), Morgan Stanley (0.87%), Morgan Stanley (0.88%), UBS Group AG (0.65%) and Raymond James & Associates (0.53%). Which institutional investors are selling Invesco Dynamic Pharmaceuticals ETF stock? PJP stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG, Wells Fargo & Company MN, Envestnet Asset Management Inc., Commonwealth Equity Services LLC, Jane Street Group LLC, Patriot Financial Group Insurance Agency LLC, BTR Capital Management Inc., and Raymond James & Associates. Which institutional investors are buying Invesco Dynamic Pharmaceuticals ETF stock? PJP stock was bought by a variety of institutional investors in the last quarter, including Advisor Group Holdings Inc., Q3 Asset Management, 55I LLC, Cambridge Investment Research Advisors Inc., Morgan Stanley, Morgan Stanley, JPMorgan Chase & Co., and Bartlett & Co. LLC. How do I buy shares of Invesco Dynamic Pharmaceuticals ETF? Shares of PJP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Invesco Dynamic Pharmaceuticals ETF's stock price today? One share of PJP stock can currently be purchased for approximately $64.22. How big of a company is Invesco Dynamic Pharmaceuticals ETF? Invesco Dynamic Pharmaceuticals ETF has a market capitalization of $359.63 million. What is Invesco Dynamic Pharmaceuticals ETF's official website? The official website for Invesco Dynamic Pharmaceuticals ETF is www.invescopowershares.com. How can I contact Invesco Dynamic Pharmaceuticals ETF? Invesco Dynamic Pharmaceuticals ETF's mailing address is 301 W. Roosevelt Road, Wheaton, 60187, United States. The company can be reached via phone at +1-800-9830903. This page was last updated on 5/28/2020 by MarketBeat.com Staff
